This is a proposal for a Mid-Career Investigator Award for Katherine Luzuriaga, M.D., a physician scientist with clinical training in pediatric infectious diseases and research training in viral immunology. Over the years, her research has focused on examining the viral and immunopathologies of vertical HIV-1 infection, with the goal of improving prevention and treatment strategies. Ongoing research projects focus on characterizing viral replication and host immune responses in early infection, with a particular emphasis on characterizing HIV-1 specific CD8+ cytotoxic T lymphocyte (CTL) responses in infants. Receipt of a Mid-Career Investigator Award will permit the candidate to devote the majority of her time to patient-oriented research and mentoring the next generation of physician-scientists. The proposed studies address the hypothesis that the role of HIV-1 specific CTL in the control of viremia and protection against disease progression is dependent not only on the time of detection, magnitude, and breadth of the responses but also on CTL functional properties. Novel and extremely sensitive flow- cytometry (MHC-peptide tetramers; intracellular chemokine/cytokine) or modified ELISA (ELISPOT)-based techniques will be used to enumerate HIV-1 specific CTL in serial blood samples from infected infants. The use of monoclonal antibodies to cell surface antigens, along with tetramer staining, will allow evaluation of the in vivo phenotypes and activation state of HIV-1 specific CTL. HIV-1 specific CTL clones will then be derived to evaluate lytic and other functional properties in vitro. As a faculty member at the University of Massachusetts Medical School (UMMS) Dr. Luzuriaga enjoys and is highly committed to training the next generation of physician-scientists. A mentoring plan is outlined which will provide trainees with a range of activities that will prepare them to become independent investigators.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24HD001489-01
Application #
6146226
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Serchuck, Leslie
Project Start
2000-08-04
Project End
2005-07-31
Budget Start
2000-08-04
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$76,438
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Pediatrics
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
McManus, Margaret; Mick, Eric; Hudson, Richard et al. (2016) Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants. PLoS One 11:e0154391
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Kishko, Michael; Somasundaran, Mohan; Brewster, Frank et al. (2011) Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology 8:67
Mehta, Nishaki; Cunningham, Coleen K; Flynn, Patricia et al. (2010) Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination. Vaccine 28:3672-8
Sophan, Sam; Meng, Chhour Y; Pean, Polidy et al. (2010) Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART). Southeast Asian J Trop Med Public Health 41:126-37
Mehta, Nishaki; Trzmielina, Sonia; Nonyane, Bareng A S et al. (2009) Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR. PLoS ONE 4:e5819
Greenough, Thomas C; Cunningham, Coleen K; Muresan, Petronella et al. (2008) Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy. Vaccine 26:6883-93
Gibson, Laura; Dooley, Sheryl; Trzmielina, Sonia et al. (2007) Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis 195:1789-98
Luzuriaga, Katherine; Newell, Marie-Louise; Dabis, Francois et al. (2006) Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities. Lancet 368:511-21
Scott, Z A; Chadwick, E G; Gibson, L L et al. (2001) Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol 167:7134-40